04 June 2025

‘Major step forward’: TGA approves first pharmacological therapy for OSA

5 minute read

The dual GLP-1/GIP receptor agonist tirzepatide can now be used to treat the condition in some patients. See who is eligible.

This content is for members only.
Login Join Now

End of content

No more pages to load

Username

Password

Confirm Password

First Name

Last Name

Email Address

Full Name LEAVE THIS BLANK

What field do you work in?

Specialty:

Type of University work:

Industry Specialty:

Other:

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

Processing...